Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 2Vomiting 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nausea 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Esophageal Stenosis 1Enteropathy-Associated T-Cell Lymphoma 1Burkitt Lymphoma 1Barrett Esophagus 1

Interventions

Ondansetron 3Granisetron 3Aprepitant 2casopitant 1Vincristine 1Tropisetron 1Therapeutics 1Rituximab 1R-CHOP protocol 1Psychiatric Rehabilitation 1Prochlorperazine 1Prednisolone 1Palonosetron 1Metoclopramide 1Lorazepam 1Exercise 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Antiemetics 1Acupuncture Points 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Vomiting × Prednisolone × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡